Drug Profile
Research programme: glioblastoma therapy - Royer Biomedical
Alternative Names: AppliGel - 5-FU; Fluorouracil implant - Royer BiomedicalLatest Information Update: 11 Dec 2021
Price :
$50
*
At a glance
- Originator Royer Biomedical
- Class Antineoplastics; Pyrimidinones; Small molecules
- Mechanism of Action DNA synthesis inhibitors; Thymidylate synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Glioblastoma
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Glioblastoma in USA (Intracerebral, Implant)
- 06 Jun 2012 Early research in Glioblastoma in USA (Intracranial)